Patents by Inventor Kevin Edward Loewke

Kevin Edward Loewke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11808760
    Abstract: A system and process use artificial intelligence to evaluate the toxicity of drugs on cells. In some embodiments, a convolutional neural network is trained to identify features in cells and thereafter identify when structural changes in cells are signs of damage from exposure to a drug. Some embodiments use a 2-class deep neural network, comparing drug-treated cells to controls, to learn which images may show signs of toxicity as a result of the drug. In some applications, the system may capture images from a time-lapse experiment to determine from the cell cultures how a drug affects a cell type over time.
    Type: Grant
    Filed: February 14, 2020
    Date of Patent: November 7, 2023
    Assignee: CURI BIO, INC.
    Inventors: Seyyedeh Mahnaz Maddah, Kevin Edward Loewke